A Phase II trial of Zoladex combined with CEF chemotherapy as neoadjuvant therapy in premenopausal women with hormone-responsive, operable breast cancer
Sheng Zhang, Chongjian Zhang, Jingjing Liu, Li Qin, Shude Cui, Jin ZhangVolume:
29
Language:
english
Pages:
7
DOI:
10.1007/s12032-011-9883-2
Date:
June, 2012
File:
PDF, 174 KB
english, 2012